Related Experiment Videos
Primary skeletal Ewing's sarcoma in Down syndrome
J A Bridge1, J R Neff, D A Borek
1Department of Pathology and Oncology, University of Kansas Medical Center, Kansas City 66103.
Cancer Genetics and Cytogenetics
|July 1, 1990
Summary
This study reports two cases of primary skeletal Ewing's sarcoma in teenagers with Down syndrome. Trisomy 21 may play a role in the development of these rare sarcomas.
Area of Science:
- Oncology
- Genetics
- Pediatric Medicine
Background:
- Ewing's sarcoma is a rare bone cancer primarily affecting children and young adults.
- Down syndrome, characterized by trisomy 21, is associated with an increased risk of certain cancers, but not typically bone sarcomas.
Observation:
- Two teenage patients with Down syndrome were diagnosed with primary skeletal Ewing's sarcoma.
- Cytogenetic analysis of one tumor revealed the characteristic 11;22 translocation of Ewing's sarcoma.
- Additional complex karyotypic abnormalities were noted in the tumor.
Findings:
- The occurrence of skeletal Ewing's sarcoma in individuals with Down syndrome is exceptionally rare.
- The presence of trisomy 21 alongside the typical Ewing's sarcoma translocation suggests potential interactions in tumorigenesis.
- Complex chromosomal aberrations may contribute to the development of these tumors in this specific population.
Implications:
- This case series highlights a potential, though not fully understood, link between Down syndrome and skeletal Ewing's sarcoma.
- Further research is warranted to investigate the role of constitutional trisomy 21 in the pathogenesis of Ewing's sarcoma.
- Understanding these genetic interactions could inform future risk assessment and therapeutic strategies for pediatric sarcoma patients with chromosomal abnormalities.